Introduction: Papillary thyroid cancer (PTC) is the most epidemic type of thyroid cancers, accounting for approximately 80% of all diagnosed thyroid cancers. Objectives: The main objective of the study is to compare the haemogram parameters of patients with thyroid papillary cancer. Material and methods: This descriptive study was conducted in Gujranwala Medical College, Gujranwala during March 2019 to December 2019. Data related to PTC patients and those with nodular hyperplasia (NH). Age, gender, thyroid stimulating hormone (TSH) levels were noted. PTC patients were graded according to the tumour nodule metastasis (TNM) stages of the American Joint Committee on Cancer (AJCC) and only those with stage 1 were included as the number of patie...
Purpose: In this study, we compared papillary thyroid carcinoma (PTC) and papillary microcarcinoma (...
Objectives:To assess the changes in parameters of thyroid carcinoma, particularly papillary type, in...
Introduction: Thyroid nodule has 5-10% malignancy rate in Malaysia. TIRADS 3 and 4A category pati...
Aim: Papillary thyroid carcinoma (PTC) is the most common primary thyroid malignancy. It is called p...
Background and Objectives : Distinguishing benign from malignant lesion in thyroid noddex is importa...
Introduction: Thyroid swelling remains a problem of enormous magnitude all over the world. The probl...
Objective: Neutrophil lymphocyte ratio (N/L) and mean platelet (Plt) volume (MPV), the markers of sy...
Background & aim: One of the most common clinical problems among individuals is thyroid nodule disea...
Introduction: The most common type of endocrine malignancy is thyroid cancer (TC). TC is the 7th, 14...
The aim: To evaluate relations between morphological features of papillary thyroid carcinoma (PTC) a...
Objectives: Inflammatory markers such as neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lympho...
Introduction: Cancer is becoming a leading cause of death in many countries of the world. Thyroid ca...
Thyroid nodules that are read on cytology as follicular or Hu¨ rthle cell neoplasms (FN and HN, resp...
Introduction: Thyroid cancer is ranked fourth in a state of Kelantan, while ranked much lower in oth...
Purpose: Recently, there have been an increasing number of studies indicating that Florine-18 fluoro...
Purpose: In this study, we compared papillary thyroid carcinoma (PTC) and papillary microcarcinoma (...
Objectives:To assess the changes in parameters of thyroid carcinoma, particularly papillary type, in...
Introduction: Thyroid nodule has 5-10% malignancy rate in Malaysia. TIRADS 3 and 4A category pati...
Aim: Papillary thyroid carcinoma (PTC) is the most common primary thyroid malignancy. It is called p...
Background and Objectives : Distinguishing benign from malignant lesion in thyroid noddex is importa...
Introduction: Thyroid swelling remains a problem of enormous magnitude all over the world. The probl...
Objective: Neutrophil lymphocyte ratio (N/L) and mean platelet (Plt) volume (MPV), the markers of sy...
Background & aim: One of the most common clinical problems among individuals is thyroid nodule disea...
Introduction: The most common type of endocrine malignancy is thyroid cancer (TC). TC is the 7th, 14...
The aim: To evaluate relations between morphological features of papillary thyroid carcinoma (PTC) a...
Objectives: Inflammatory markers such as neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lympho...
Introduction: Cancer is becoming a leading cause of death in many countries of the world. Thyroid ca...
Thyroid nodules that are read on cytology as follicular or Hu¨ rthle cell neoplasms (FN and HN, resp...
Introduction: Thyroid cancer is ranked fourth in a state of Kelantan, while ranked much lower in oth...
Purpose: Recently, there have been an increasing number of studies indicating that Florine-18 fluoro...
Purpose: In this study, we compared papillary thyroid carcinoma (PTC) and papillary microcarcinoma (...
Objectives:To assess the changes in parameters of thyroid carcinoma, particularly papillary type, in...
Introduction: Thyroid nodule has 5-10% malignancy rate in Malaysia. TIRADS 3 and 4A category pati...